Caesalpinia sappan: A promising natural source of antimicrobial agent for inhibition of cariogenic bacteria

Drug Discoveries & Therapeutics
Rinrampai PuttipanSiriporn Okonogi

Abstract

From the previous findings, the ethanolic fractionated extract of Caesalpinia sappan (F-EtOH) has high activity against Streptococcus mutans, the most severe cariogenic bacteria. The present study was aimed to isolate and identify the active compound of F-EtOH and compare its inhibitory activity against the biofilm of S. mutans as well as the cytotoxicity to oral fibroblast cells with F-EtOH. Compound isolation was done by column chromatography. The active compound was identified using liquid chromatography-mass spectrometry with electrospray ionization and nuclear magnetic resonance spectroscopy. It was found that the major compound of F-EtOH is brazilin. F-EtOH and brazilin were compared for inhibitory potential on the biofilms of three strains of S. mutans. The results exhibited that both F-EtOH and brazilin had potential on inhibiting biofilm formation and eradicating the preformed biofilms and their activity was dose dependent. F-EtOH showed significantly less toxic to normal periodontal ligament fibroblast than brazilin. At low concentration of 1- and 2-MBC, F-EtOH showed higher effective than brazilin. The results of our study suggest that the antibacterial activity of F-EtOH is according to the synergistic effects of th...Continue Reading

References

Oct 13, 2001·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Y C ChangM Y Chou
Oct 12, 2004·Phytotherapy Research : PTR·Hong-Xi Xu, Song F Lee
Nov 8, 2005·Journal of Clinical Microbiology·Jørn A AasFloyd E Dewhirst
Jan 10, 2006·Periodontology 2000·Antonio Nanci, Dieter D Bosshardt
Jan 5, 2007·Biological & Pharmaceutical Bulletin·Yohei SasakiSeiji Nagumo
May 14, 2009·DNA and Cell Biology·Jens KrethFengxia Qi
Jun 2, 2010·Nature Reviews. Microbiology·Paul E KolenbranderNicholas S Jakubovics
Jul 22, 2010·Journal of Dentistry·P D Marsh
Dec 15, 2010·Antimicrobial Agents and Chemotherapy·Xin XuChristine D Wu
Sep 20, 2011·Current Opinion in Biotechnology·Maria Daglia
Jan 10, 2012·Archives of Oral Biology·Baruch NarotzkiYishai Levy
Nov 7, 2012·Bioorganic & Medicinal Chemistry Letters·Byung Sun MinMi Hee Woo
Jun 20, 2013·Archives of Oral Biology·Ping HuMin Wei Chen
Aug 27, 2014·Chinese Journal of Natural Medicines·Qing ZhangQiang Yu
Aug 30, 2014·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Vinoth ShanmugamRamaswamy Murugan
Jul 22, 2015·Asian Pacific Journal of Tropical Medicine·Nilesh P NirmalMehraj Ahmad
Apr 1, 2017·Frontiers in Microbiology·Caroline S RempeC Neal Stewart
Mar 1, 2013·Integrative Medicine Research·Nam-Hui YimJin Yeul Ma
Jan 16, 2018·Drug Discoveries & Therapeutics·Rinrampai PuttipanSiriporn Okonogi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.